VICL - Vical Incorporated

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.34
-0.04 (-1.68%)
As of 11:36AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close2.38
Open2.36
Bid2.33 x 2000
Ask2.38 x 300
Day's Range2.34 - 2.42
52 Week Range2.05 - 3.70
Volume84,061
Avg. Volume262,630
Market Cap26.68M
Beta1.06
PE Ratio (TTM)-2.24
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube8 days ago

    ETFs with exposure to Vical, Inc. : October 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vical, Inc. Here are 5 ETFs with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Vical, Inc. : September 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vical, Inc. Here are 5 ETFs with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Vical, Inc. :VICL-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
    Capital Cubelast month

    Vical, Inc. :VICL-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Vical, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Vical, Inc. – CytRx Corporation, Newlink Genetics Corporation, Agenus Inc., Chimerix, Inc., Celldex Therapeutics, Inc., Sanofi Sponsored ADR, Pfizer Inc., Merck & Co., Inc. and Bristol-Myers Squibb Company (CYTR-US, ... Read more (Read more...)

  • Thomson Reuters StreetEventslast month

    Edited Transcript of VICL earnings conference call or presentation 8-Aug-17 4:00pm GMT

    Q2 2017 Vical Inc Earnings Call

  • Associated Press2 months ago

    Vical reports 2Q loss

    The San Diego-based company said it had a loss of 30 cents per share. The drug developer posted revenue of $3.4 million in the period. The company's shares closed at $2.59. A year ago, they were trading ...

  • Capital Cube4 months ago

    ETFs with exposure to Vical, Inc. : June 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vical, Inc. Here are 5 ETFs with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Vical, Inc. : June 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vical, Inc. Here are 5 ETFs with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Vical, Inc. :VICL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017
    Capital Cube4 months ago

    Vical, Inc. :VICL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Vical, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Vical, Inc. – CytRx Corporation, Newlink Genetics Corporation, Chimerix, Inc., Agenus Inc., Celldex Therapeutics, Inc., Pfizer Inc., Merck & Co., Inc. and Bristol-Myers Squibb Company (CYTR-US, NLNK-US, CMRX-US, AGEN-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of VICL earnings conference call or presentation 15-May-17 4:00pm GMT

    Q1 2017 Vical Inc Earnings Call

  • Associated Press5 months ago

    Vical reports 1Q loss

    The San Diego-based company said it had a loss of 25 cents per share. The drug developer posted revenue of $3.2 million in the period. The company's shares closed at $2.26. A year ago, they were trading ...

  • Capital Cube6 months ago

    ETFs with exposure to Vical, Inc. : April 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vical, Inc. Here are 5 ETFs with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Vical, Inc. :VICL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 15, 2017
    Capital Cube7 months ago

    Vical, Inc. :VICL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis Vical, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Vical, Inc. – Chimerix, Inc., Agenus Inc., Newlink Genetics Corporation, Celldex Therapeutics, Inc., Sanofi Sponsored ADR, Pfizer Inc., Merck & Co., Inc. and Bristol-Myers Squibb Company (CMRX-US, AGEN-US, NLNK-US, ... Read more (Read more...)

  • Associated Press7 months ago

    Vical reports 4Q loss

    The San Diego-based company said it had a loss of 25 cents per share. The drug developer posted revenue of $3.2 million in the period. For the year, the company reported that its loss narrowed to $9 million, ...

  • Capital Cube9 months ago

    ETFs with exposure to Vical, Inc. : January 6, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Vical, Inc. Here are 5 ETFs with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube10 months ago

    ETFs with exposure to Vical, Inc. : December 13, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Vical, Inc. Here are 5 ETFs with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube11 months ago

    ETF’s with exposure to Vical, Inc. : November 7, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Vical, Inc. Here are 5 ETF’s with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cubelast year

    ETF’s with exposure to Vical, Inc. : October 25, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Vical, Inc. Here are 5 ETF’s with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)